Sunday, 21 July 2024



LATEST NEWS Significant step towards Waste Management in Haryana: Two Waste-to-Charcoal Plants to be set up in the State State-Level ceremony held to celebrate Maharaja Daksha Prajapati Jayanti in Hisar Para cricketer Aamir Hussain Lone meets Governor at Raj Bhavan DLSA plants saplings in jail complex "Punjab government fully prepared to deal with floods - Kuldeep Singh Dhaliwal S.A.S Nagar Location of the Help Desk Changed from Sub Registrar Office Entry to SDM Office Ved Vihar Public School Educational Society donates over Rs. 1.5 Crore towards Mukhya Mantri Sukh Aashray Kosh Cricketer Hardik Pandya Net Worth, Bio, Career, Lifestyle, And Family 2024 | 5 Dariya News Brig. Saket Singh Call on Lt Governor Manoj Sinha Maushumi Chakravarty Call Lt Governor Manoj Sinha SANJY-2024: Nukkad Natak Show raises awareness about Safe Sanitation practices, Stop Diarrhea Campaign at Nunwan Basecamp Cong and allies systematically denigrating security forces : Devender Singh Rana DC Rajouri Om Prakash Bhagat reviews functioning of Social Welfare & ICDS Department Muharram-2024: DC Bandipora Shakeel-ul-Rehman Rather participates in Mourning Procession at Sumbal DC Srinagar Dr Bilal Mohi-Ud-Din Bhat chairs meeting on Swachta Green Leaf Rating DC Srinagar Dr. Bilal Mohi-Ud-Din Bhat chairs Annual General Body meeting of Zila Sanik Welfare Board Union Joint Secretary Rajender Kumar reviews Jal Shakti Abhiyan: Catch the Rain in Jammu Chief Secretary Atal Dulloo reviews progress J&K EPFO transition to Central EPFO DC Srinagar Dr Bilal Mohi-Ud-Din Bhat conducts extensive tour of City; inspects progress on various developmental projects Director Agriculture reviews Physical/ Financial achievements under HADP, CAPEX & CSS implementation DC Bandipora Shakeel-ul-Rehman Rather visits Ziyarat Sharief Hazrat Nanga Baji Sahib, Malangam


Unprecedented Study Shows Spontaneous Reversal of Fatal Heart Condition in Three Men

Health, Research, University College London ,Royal Free Hospital UK, Transthyretin Cardiac Amyloidosis, The New England Journal of Medicine, Heart Conditions, Fatal Heart Condition, Fatal Heart Conditions In Men, Men Fatal Heart Conditions, Marianna Fontana, Men Heart Conditions, Men Heart Conditions Study
Listen to this article

Web Admin

Web Admin

5 Dariya News

London , 12 Jun 2023

In a groundbreaking study conducted by researchers from the University College London and the Royal Free Hospital in the UK, three men with a fatal heart condition experienced a remarkable reversal of their symptoms. The condition, known as transthyretin cardiac amyloidosis, is caused by the accumulation of sticky and toxic proteins in the heart. Until now, it has been considered as a progressive and irreversible disease, with a high mortality rate within four years of diagnosis.

The three men, aged 68, 76, and 82, were diagnosed with transthyretin cardiac amyloidosis and were enrolled in the study. The researchers closely monitored their progress and documented significant improvements in their health. Their findings were published as a letter in The New England Journal of Medicine.

To confirm the men's recoveries, the researchers utilized various diagnostic tools, including blood tests and imaging techniques such as echocardiography and cardiovascular magnetic resonance (CMR) scans. These tests revealed that the buildup of amyloid proteins in the heart had disappeared, and the structure and function of the heart had returned to a near-normal state. Additionally, scintigraphy and exercise capacity assessments further supported the evidence of improvement.

Also Read: How stress ups risk of cancer, heart disease

Lead author Professor Marianna Fontana from UCL's Division of Medicine expressed the significance of the study's findings, stating, "We have seen for the first time that the heart can get better with this disease. That has not been known until now and it raises the bar for what might be possible with new treatments."

The researchers also made a noteworthy discovery related to the immune response of the three men. They found evidence of antibodies specifically targeting the amyloid proteins, which were absent in other patients whose conditions progressed as expected. Although the exact causal relationship between these antibodies and the recovery remains to be conclusively proven, Professor Julian Gillmore, head of the UCL Centre for Amyloidosis, suggested that there is potential for these antibodies to be recreated in a lab and used as a therapeutic approach.

Whereas, Professor Gillmore emphasised that further investigation is required, and the research is still at a preliminary stage. However, if the antibodies could be harnessed, they could be combined with ongoing trials of new therapies that suppress the production of transthyretin (TTR) protein. This combination approach may enable clinicians to not only clear away existing amyloid but also prevent further deposition, providing hope for future treatments.

The study's findings present a promising breakthrough in the field of cardiac amyloidosis, offering new insights into the potential for reversing this once-deemed irreversible condition. The possibility of harnessing antibodies and combining them with targeted therapies has raised hopes for improved treatment options for patients in the future.

Also Read: New lab grown mini heart chamber may help speed heart disease cures


Health , Research , University College London , Royal Free Hospital UK , Transthyretin Cardiac Amyloidosis , The New England Journal of Medicine , Heart Conditions , Fatal Heart Condition , Fatal Heart Conditions In Men , Men Fatal Heart Conditions , Marianna Fontana , Men Heart Conditions , Men Heart Conditions Study



related news




Photo Gallery



Video Gallery



5 Dariya News RNI Code: PUNMUL/2011/49000
© 2011-2024 | 5 Dariya News | All Rights Reserved
Powered by: CDS PVT LTD